Versant Capital Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $456K | Sell |
1,169
-489
| -29% | -$207K | 0.04% | 321 |
|
|
2026
Q1 | $785K | Buy |
1,658
+301
| +22% | +$152K | 0.08% | 158 |
|
|
2025
Q4 | $634K | Buy |
1,357
+109
| +9% | +$50.6K | 0.08% | 165 |
|
|
2025
Q3 | $532K | Buy |
1,248
+23
| +2% | +$8.91K | 0.07% | 190 |
|
|
2025
Q2 | $469K | Buy |
1,225
+637
| +108% | +$230K | 0.07% | 187 |
|
|
2025
Q1 | $203K | Buy |
588
+185
| +46% | +$59.5K | 0.03% | 419 |
|
|
2024
Q4 | $121K | Buy |
403
+71
| +21% | +$24.8K | 0.03% | 260 |
|
|
2024
Q3 | $135K | Buy |
332
+83
| +33% | +$30.4K | 0.03% | 193 |
|
|
2024
Q2 | $80K | Buy |
249
+176
| +241% | +$57.2K | 0.02% | 250 |
|
|
2024
Q1 | $24.3K | Hold |
73
| – | – | 0.01% | 447 |
|
|
2023
Q4 | $19.8K | Buy |
73
+3
| +4% | +$741 | 0.01% | 502 |
|
|
2023
Q3 | $17.2K | Sell |
70
-1
| -1% | -$274 | 0.01% | 530 |
|
|
2023
Q2 | $21.5K | Buy |
71
+6
| +9% | +$1.67K | 0.01% | 484 |
|
|
2023
Q1 | $17.1K | Buy |
65
+52
| +400% | +$13.2K | 0.01% | 538 |
|
|
2022
Q4 | $3.12K | Hold |
13
| – | – | ﹤0.01% | 1024 |
|
|
2022
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 1077 |
|
|
2022
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 1097 |
|
|
2022
Q1 | $3K | Hold |
13
| – | – | ﹤0.01% | 1031 |
|
|
2021
Q4 | $3K | Hold |
13
| – | – | ﹤0.01% | 1032 |
|
|
2021
Q3 | $3K | Hold |
13
| – | – | ﹤0.01% | 1040 |
|
|
2021
Q2 | $3K | Hold |
13
| – | – | ﹤0.01% | 1043 |
|
|
2021
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 1236 |
|
|
2020
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 1120 |
|
|
2020
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1176 |
|
|
2020
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1169 |
|
|
2020
Q1 | $1K | Sell |
13
-6
| -32% | -$777 | ﹤0.01% | 1145 |
|
|
2019
Q4 | $2K | Sell |
19
-24
| -56% | -$3.22K | ﹤0.01% | 1138 |
|
|
2019
Q3 | $5K | Hold |
43
| – | – | ﹤0.01% | 947 |
|
|
2019
Q2 | $5K | Sell |
43
-14
| -25% | -$1.77K | ﹤0.01% | 958 |
|
|
2019
Q1 | $7K | Hold |
57
| – | – | ﹤0.01% | 1014 |
|
|
2018
Q4 | $7K | Hold |
57
| – | – | ﹤0.01% | 925 |
|
|
2018
Q3 | $7K | Hold |
57
| – | – | ﹤0.01% | 987 |
|
|
2018
Q2 | $5K | Hold |
57
| – | – | ﹤0.01% | 1083 |
|
|
2018
Q1 | $5K | Sell |
57
-13
| -19% | -$1.26K | ﹤0.01% | 1063 |
|
|
2017
Q4 | $6K | Sell |
70
-11
| -14% | -$884 | ﹤0.01% | 1066 |
|
|
2017
Q3 | $6K | Sell |
81
-24
| -23% | -$1.93K | ﹤0.01% | 1004 |
|
|
2017
Q2 | $9K | Buy |
105
+11
| +12% | +$931 | 0.01% | 894 |
|
|
2017
Q1 | $8K | Sell |
94
-5
| -5% | -$417 | ﹤0.01% | 911 |
|
|
2016
Q4 | $7K | Sell |
99
-53
| -35% | -$3.97K | ﹤0.01% | 933 |
|
|
2016
Q3 | $11K | Sell |
152
-7
| -4% | -$536 | 0.01% | 776 |
|
|
2016
Q2 | $12K | Buy |
159
+5
| +3% | +$395 | 0.01% | 716 |
|
|
2016
Q1 | $12K | Buy |
154
+60
| +64% | +$4.19K | 0.01% | 698 |
|
|
2015
Q4 | $6K | Buy |
+94
| New | +$6.56K | ﹤0.01% | 885 |
|
Other funds holding HCA
MIHAS
ACM
FWIA
SJL
WCM
AIM
AT
GIA
Versant Capital Management's HCA Position: Q2 2026 in Review
Versant Capital Management reduced its HCA Healthcare (HCA) stake by 29% in Q2 2026, selling an estimated $207K and leaving 1,169 shares worth $456K. The position accounts for 0.04% of the portfolio, ranked #321.
Versant Capital Management first reported a position in HCA in Q4 2015 and has held it in 43 quarters since. The position peaked at $785K in Q1 2026. 216 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Versant Capital Management held 1,169 shares of HCA Healthcare worth $456K as of Q2 2026.
- Versant Capital Management sold 489 HCA Healthcare shares in Q2 2026, an estimated $207K.
- HCA Healthcare made up 0.04% of Versant Capital Management's portfolio in Q2 2026, its #321 holding.
- Versant Capital Management first reported a position in HCA Healthcare in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's HCA Healthcare position peaked at $785K in Q1 2026.
- 216 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.